JERUSALEM PHARMACEUTICALS(JPH) disclosed its financial statements for the second quarter of the year 2025.
| Disclosure Year | 2025 | 2024 | ||
| Disclosure Period | End of 30\06 | End of 30\06 | ||
| Disclosure Start Date | 01/01/2025 | 01/01/2024 | ||
| Disclosure End Date | 30/06/2025 | 30/06/2024 | ||
| Disclosure Type | Financial Disclosure | Financial Disclosure | ||
| Company's Name | JERUSALEM PHARMACEUTICALS | JERUSALEM PHARMACEUTICALS | ||
| Company Symbol | JPH | JPH | ||
| Sector | Industry Sector | Industry Sector | ||
| Currency | USD | USD | ||
| End date of legal disclosure period | 17/08/2025 | 15/09/2024 | ||
| Actual Disclosure Date | 06/08/2025 07:07:00 PM | 12/08/2024 04:52:00 PM | ||
| Hard Copy Disclosure | ||||
| Hard Copy Disclosure-English Version | ||||
| Consolidation Status | Consolidated | Consolidated | ||
| Notes Display Source | Note ID Only | Note ID Only | ||
| Auditing Status | Reviewed | Audited | ||
| Net income in Cash Flow Statement | Income Before Tax | Income Before Tax | ||
| Net income used in calculating the press release | 144,382 | - |
The attached notes form part of these financial statements
Comments